The UniSpace ® Stand-Alone C Cage has several key features that distinguish it as an advanced solution in spinal fusion technology. Its biomimetic lattice scaffolding, featuring a large graft window and two distinct porosity zones, facilitates enhanced bone formation by promoting both on growth and in growth while minimizing subsidence.
The integration of self-locking screws with an automatic locking mechanism ensures secure fixation, further supported by visual confirmation of the locking mechanism. Crafted from 3D-printed porous titanium material, the cage offers optimal osseointegration. Its adaptive sizing and variable angle screws allow for customized fit and optimized screw angulation, while an optional locking plate provides additional security against screw backout.
These features collectively enhance the efficacy and stability of spinal fusion procedures, exemplifying the UniSpace® Stand-Alone C Cage as a cutting-edge solution in orthopedic surgery.
Product Feature
1. Biomimetic Lattice Scaffolding with a Large Graft Window:
Enhances both ongrowth and ingrowth.
2. Primary Automatic Locking Mechanism:
Prevents screw backout.
3. Integrated Locking Mechanism for Visual Confirmation:
Allows for visual confirmation of proper screw placement and locking.
INDICATIONS FOR USE
The UniSpace® Stand-Alone C Cage is a standalone anterior cervical interbody fusion device indicated for skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc. Cervical disc disease is defined as intractable radiculopathy and/or myelopathy with herniated disc and/or osteophyte formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. The UniSpace® Stand-Alone C Cage implants are to be used with either autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft and implanted via an open, anterior approach. The Cages of the UniSpace® Stand-Alone C Cage must be used with the two internal fixation screws provided. The Cages with ≥ 20° lordosis must be used with an additional supplemental fixation system that has been cleared by the FDA for use in the cervical spine, in addition to the two integrated fixation screws provided. This cervical device is to be used in patients who have had six weeks of non-operative treatment.
